Sarcopenic Obesity: Time to Meet the Challenge
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
The prevalence of overweight and obesity has reached epidemic proportions worldwide due to increasingly pervasive obesogenic lifestyle changes. Obesity poses unprecedented individual, social, and multidisciplinary medical challenges by increasing the risk for metabolic diseases, chronic organ failures, and cancer as well as complication rates in the presence of acute disease conditions. Whereas reducing excess adiposity remains the fundamental pathogenic treatment for obese individuals, complex metabolic and lifestyle abnormalities as well as weight reduction therapies per se may also compromise the ability to preserve muscle function and mass, especially when chronic disease co-exists with obesity. Emerging evidence indicates that low muscle mass and quality have a strong negative prognostic impact in obese individuals and may lead to frailty, disability, and increased morbidity and mortality. Awareness of the importance of skeletal muscle maintenance in obesity is however low among clinicians and scientists. The term ‘sarcopenic obesity' has been proposed to identify obesity with low skeletal muscle function and mass, but its utilization is largely limited to the aging patient population, and consensus on its definition and diagnostic criteria remains insufficient. Knowledge on prevalence of sarcopenic obesity in various clinical conditions and patient subgroups, on its clinical impacts in patient risk stratification, and on effective prevention and treatment strategies remain therefore dramatically inadequate. In particular, optimal dietary options and medical nutritional support strategies to preserve muscle mass in obese individuals remain largely undefined. The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) recognize and indicate obesity with altered body composition due to low skeletal muscle function and mass (sarcopenic obesity) as a scientific and clinical priority for researchers and clinicians. ESPEN and EASO therefore call for coordinated action aimed at reaching consensus on its definition, diagnostic criteria, and optimal treatment with particular regard to nutritional therapy. We are convinced that achievement of these goals has a strong potential to reduce the burden of morbidity and mortality in the rapidly increasing obese patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consensus statements have emphasized that SO should be understood as a disorder of body composition and function rather than as a simple coexistence of two diagnoses (1, 2).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“cytokines produced by infiltrating cells such as macrophages can cause muscular atrophy by inducing filament protein degradation and apoptosis (21).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [21]
In the citing paper
“Indeed, there are multiple biological effects of physical activity: promote insulin sensitivity, improve anabolic response to endogenous amino acids, activate skeletal muscle satellites cells and trigger the proliferation and differentiation of them, amplify irisin production, adjust hormonal milieu, increase mitochondrial biogenesis, ameliorate inflammation and reduce oxidative stress (162–164).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“…: clustered metabolic de-rangements including systemic and muscle oxidative stress, in fl ammation and insulin resistance may occur in obesity [17 e 20] due to various causes that primarily include a) excess nutrient availability and tissue delivery, particularly saturated fat [28] and…”
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058 · cited 2×
“Reducing excess adiposity remains the fundamental pathogenetic treatment for obese individuals [15,16].”
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“Indeed low or declining muscle mass is emerging as a negative prognostic factor associated with higher morbidity and mortality in obese patients with chronic diseases [67 e 69].”
Cited by
Items 101–200 of 244
Choi, S., Chon, J., Yoo, M. C., Shim, G. Y., Kim, M., Soh, Y., & Won, C. W. (2024) · Medicina · doi:10.3390/medicina60050754 · Cited by 11
Wu, H., Chen, X., Shi, Z., Liu, J., Meng, Z., Zheng, C., & Zhou, C.-J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1428856 · Cited by 10
Yu, C., Meng, Z., Wang, X., & Xiao, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-24746-1 · Cited by 13
“Although there is no universally accepted definition of sarcopenic obesity, it generally refers to a decrease in muscle strength and mass combined with a high level of obesity [6, 7].”
Role of MiR-325-3p in the Regulation of CFL2 and Myogenic Differentiation of C2C12 Myoblasts
Nguyen, M. T., & Lee, W. (2021) · Cells · doi:10.3390/cells10102725 · Cited by 9
“Recently, it was suggested that obesity exacerbates the detrimental consequences of muscle wasting and leads to sarcopenic obesity [5,6].”
BackgroundSarcopenia, obesity, and diabetes – The metabolic conundrum trifecta
Jayasinghe, S. U., & Hills, A. P. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102656 · Cited by 10
Silveira, É. A., de Souza, J. D., Santos, A. S. E. A. D. C., Canheta, A. B. D. S., Pagotto, V., & Noll, M. A. (2020) · Archives of Public Health · doi:10.1186/s13690-020-00454-7 · Cited by 13
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women
Park, J. Y., Chung, Y., Song, J., Kil, K., Lee, H. Y., Chae, J., & Kim, J.-H. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24004 · Cited by 12
Ling, C.-J., Chen, X., Xu, J., Wang, G., Wang, Y., Sun, Y., Li, Y., Wan, Z., Tong, X., Hidayat, K., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105241 · Cited by 10
Miedany, Y. M. E., Mahran, S., & Elwakil, W. (2023) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-023-00199-5 · Cited by 9
“Sarcopenic obesity is a clinical and functional condition marked by the coexistence of obesity (excess fat mass) and sarcopenia [39].”
BackgroundLou, Y., Xie, Y., Jiang, Q., Huang, S., Wang, X., Wang, L., Wang, H., & Cao, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16016 · Cited by 9
“7,8 According to a systematic review, approximately 11% of older adults worldwide are affected by SO.”
Image-based assessment of sarcopenic obesity predicts mortality in major trauma
Oh, J. S., Ssentongo, A. E., Ssentongo, P., Dykes, T. M., Keeney, L., Armen, S. B., & Soybel, D. I. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.06.007 · Cited by 8
Role of Nutrition and Diet during COVID-19 pandemic: A narrative review
Pal, J., Sethi, D., Taywade, M., & Pal, R. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1311_21 · Cited by 9
“thus, developing a burden of malnutrition which includes both the under and over nutrition.[21] Obesity is one of the most frequently reported risk factors for contracting NCDs and organ failure, telling us how badly obesity affects health.”
BackgroundBufano, A., Cartocci, A., Benenati, N., Ciuoli, C., Batzibal, M. S., Bombardieri, A., Sareri, G. I., Sannino, I., Tirone, A., Voglino, C., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1369584 · Cited by 8
Prokopidis, K., Zhong, Z., Harding, L., & Isanejad, M. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2595744 · Cited by 7
“Conversely, females in this cohort displayed elevated BMI, potentially indicative of increased adiposity rather than preserved muscle, suggesting a phenotype akin to sarcopenic obesity that may obscure the impact of CRP on ALSTI [16].”
Gu, L., Yin, X., Cheng, Y., Wang, X., Zhang, M., Zou, X., Wang, L., Zhuge, Y., & Zhang, F. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040682 · Cited by 9
“Recently, the new concept of sarcopenic obesity identifies overweight/obesity with low skeletal muscle function and mass in patients with NAFLD and diabetes mellitus (DM) [23].”
BackgroundKim, J., Jeong, K., Lim, S., Lee, S. W., & Baek, Y.-H. (2023) · Metabolites · doi:10.3390/metabo14020130 · Cited by 8
“SO is defined as the coexistence of sarcopenia and obesity which characterized by low skeletal muscle mass and function and excess body fat mass [25].”
BackgroundMoradi, A., Hosseini, S. A., & Nikbakht, M. (2019) · Middle East Journal of Rehabilitation and Health Studies · doi:10.5812/mejrh.92612 · Cited by 7
“Then, obese rats were divided into five groups of 7 subjects including (1) control, (2) swimming training, (3) swimming training and crocin consumption, (4) crocin consumption, and (5) sham group (crocin solvent or normal saline).”
BackgroundMethodda Silva, J. S. M., Biesek, S., Vojciechowski, A. S., Borba, V. Z. C., Rabito, E. I., Gomes, A. R. S., & de Oliveira, L. A. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.12.002 · Cited by 7
Tian, M., Yuan, J., Yu, F., He, P., Zhang, Q., & Zha, Y. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04357-4 · Cited by 7
“This condition has recently attracted increased interest in both research and clinical practice because of its negative impact on patient-centred outcomes [2–7].”
BackgroundHong, C., Baek, J. Y., Lee, J. W., Lee, J. H., Lee, K., Park, T.-J., & Kim, J. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.19.0032 · Cited by 8
Role of immunity and inflammation in sarcopenic obesity
Ma, Y. F., Li, X., Lin, X., Zhang, K., & Leng, J. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110077 · Cited by 8
SAYDAM, N. H., Erdoğan, T., Sezer, D., Kılıç, C., Özkök, S., Bahat, G., & Karan, M. A. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70226 · Cited by 6
“Sarcopenic obesity is one of the geriatric syndromes that has recently gained clinical importance and is defined as the coexistence of sarcopenia and obesity, characterized by an increased fat mass percentage in line with the ESPEN/EASO consensus definition [1–3].”
Ghoch, M. E., & Pellegrini, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962895 · Cited by 8
Terminologija klinične prehrane: Motnje prehranjenosti in s prehranjenostjo povezana stanja
Kozjek, N. R., Tonin, G., Puzigaća, L., Veninšek, G., Pirkmajer, S., Božič, T. K., Mastnak, D. M., Košir, J. A., Petrica, L., Berlec, K., et al. (2023) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3446 · Cited by 22
Tian, M., Lan, Q., Yu, F., He, P., Hu, S., & Zha, Y. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0149 · Cited by 6
Association Between Adiposity Indices and Blood Pressure is Stronger in Sarcopenic Obese Women
Dutra, M. T., Martins, K. G., dos Reis, D. B. V., Silva, A. D. O., & Mota, M. R. (2018) · Current Hypertension Reviews · doi:10.2174/1573402114666181031145341 · Cited by 8
Sarcopenia prevalence and the quality of life in older adults: A study from Turkey’s east
Efe, M., Saraç, F., Savaş, S., Kilavuz, A., & Akçiçek, S. (2021) · Ege Tıp Dergisi · doi:10.19161/etd.915678 · Cited by 11
“Additionally, especially for obese patients, the value of calf circumference for determining muscle mass is not clear (45, 46).”
BackgroundPark, J. Y., Chung, Y., Song, J., Kim, C., Lee, H., Son, Y., Shin, I., Park, J. H., & Kim, J.-H. (2023) · Journal of Menopausal Medicine · doi:10.6118/jmm.23018 · Cited by 8
“SO is a clinical and functional condition characterized by the coexistence of obesity, characterized by excess fat mass (FM), and sarcopenia [17].”
BackgroundGandham, A., Prokopidis, K., Glavas, C., Scott, D., & Lorentzon, M. (2026) · Osteoporosis International · doi:10.1007/s00198-025-07801-w · Cited by 10
“Older adults are at increased risk of chronic health conditions including sarcopenia (defined as a loss of skeletal muscle mass and function), obesity, and sarcopenic obesity (defined as the comorbid presence of sarcopenia and obesity) [1–3].”
Relationships of food security with skeletal muscle mass and handgrip strength by sex
Lee, K. (2022) · Nutrition · doi:10.1016/j.nut.2022.111746 · Cited by 5
The Gravitostat theory: Body fat is lost but is fat-free mass preserved?
Thivel, D., & Boirie, Y. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100531 · Cited by 5
“This striking result is of particular relevance since, as usually observed and described in the literature, FFM is always significantly reduced in response to dietary restriction-induced weight loss of similar duration, questioning the relevance of caloric restriction in the specific situation of sarcopenic obesity [4…”
ResultSelf-citationThe impact of obesity and age on the risk of falls in elderly women
Bobowik, P. Ż., & Wiszomirska, I. (2021) · Acta of Bioengineering and Biomechanics · doi:10.37190/abb-01804-2021-03 · Cited by 6
Sarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity
Binu, A. J., Kapoor, N., Bhattacharya, S., Kishor, K., & Kalra, S. (2023) · Heart International · doi:10.17925/hi.2023.17.2.4 · Cited by 4
Zeng, D., Mizutani, K., Qi, X., Asada‐Utsugi, M., Wu, B., Kawasaki, T., Akiguchi, I., & Kinoshita, A. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05977-8 · Cited by 5
“Numerous studies have linked sarcopenia to increased risks of falls, frailty, decreased quality of life, and higher healthcare costs and mortality among this population [8–10].”
He, R., Li, P., Lang, Y., Zhu, B., Yang, X., & Li, J. (2025) · Urolithiasis · doi:10.1007/s00240-025-01783-4 · Cited by 5
“SO is a clinical condition characterized by coexisting obesity and sarcopenia, involving excess fat and low skeletal muscle mass and/or function [ 26, 27].”
Chen, L., Liao, Y., Li, Z., Yan, J., Liu, P., Sun, Y., Jin, W., Cheng, W., & Guo, J. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01940-0 · Cited by 6
“The combined effects of these two conditions could result in even more adverse health outcomes and an elevated risk of mortality [7, 8].”
Sales-Balaguer, N., Carrera, P. S., & Morillo, V. (2024) · Cancers · doi:10.3390/cancers16152738 · Cited by 4
“Major international societies point to obesity along with altered body composition as a clinical and scientific priority for practitioners [30].”
BackgroundPhysical Activity at Adulthood and Old Age
Piedade, S. R., Inada, M. M., Laurito, G. M., Paiva, D. N. E., Fraga, G. P., Pagnano, R. G., de Andrade, A. L. L., & Cardoso, T. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-10433-7_6 · Cited by 4
Itoh, S., Yoshizumi, T., & Mori, M. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.14 · Cited by 4
“The European Society for Clinical Nutrition and Metabolism and the European Association for the Study of Obesity recognize that sarcopenic obesity is defined as obesity with an altered body composition caused by low skeletal muscle mass and strength, and should be a priority for researchers and clinicians (13).”
BackgroundDynapenic Abdominal Obesity and Metabolic Health in Non-Geriatric Patients with Obesity
Akbaş, F., Atmaca, H. U., & Yazıcı, D. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0153 · Cited by 4
“11 Muscle-strengthening exercises have demonstrated the capacity to improve muscle function and strength 12 These exercises not only offer physical health advantages but also contribute to mental well-being by reducing anxiety and depression rates.”
Nam, S., Yun, H. Y., & Kim, O. (2024) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2024.2379068 · Cited by 4
“Approximately 42% of individuals with chronic SCIs have sarcopenic obesity; however, data on sarco-penic obesity in the SCI population are scarce (17).”
Stefanini, N., Martino, A. C. D., Brunello, M., Guaitoli, M. M., Censo, C. D., Geraci, G., Pilla, F., & Faldini, C. (2025) · MUSCULOSKELETAL SURGERY · doi:10.1007/s12306-025-00923-8 · Cited by 4
“…and frailty conditions is significant: there is considerable overlap between sarcopenia and several other chronic disease such as obesity [7, 8], type 2 diabetes [9], malnutrition [10], chronic cardiovascular, respiratory and kidney disease [11], and neoplasms [12] that leads to frailty…”
Yang, K., Yang, W., Si, S.-C., Liu, J., Ma, Y.-X., & Zhao, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228148 · Cited by 5
“These substances promote muscle protein degradation and muscle cell apoptosis, hence intensifying muscle atrophy [153,154].”
Mwala, N. N., Borkent, J. W., van Dronkelaar, C., Hulst, J. J. F. A. I. '., van der Meij, B. S., Soeters, M. R., & de van der Schueren, M. A. E. (2025) · Obesity Reviews · doi:10.1111/obr.70033 · Cited by 4
“Consequently, managing chronic conditions in individuals with obesity becomes more complex, leading to higher surgical risks and accelerated progression of diseases such as congestive heart failure and diabetes [11].”
Abdominal Morphologic Changes in MRI during Gastric Balloon Therapy
Keßler, R., Glitsch, A., Hübner, B., Gärtner, S., Steveling, A., Patrzyk, M., & Keßler, W. (2022) · Obesity Facts · doi:10.1159/000526444 · Cited by 3
Hashim, N. N. A., Mat, S., Myint, P. K., Kioh, S. H., Delibegović, M., Chin, A., Kamaruzzaman, S. B., Hairi, N. N., Khoo, S. P. K., & Tan, M. P. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087358 · Cited by 5
Godziuk, K., Prado, C. M. M., Woodhouse, L. J., & Forhan, M. A. (2021) · Obesity · doi:10.1002/oby.23074 · Cited by 5
“Sex differences in the pathogenesis of sarcopenic obesity (30,31) are likely, as suggested by the body composition values in our cohort.”
BackgroundJúnior, P. R. H., Brandão, B. C., Lopes, P. D. A. C., Sardeli, A. V., & Côrtes, P. P. D. R. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n4-266 · Cited by 3
Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study
Dionyssiotis, Y., Prokopidis, K., Trovas, G., Papadatou, M.-C., Ananidis, N., Tragoulias, V., Lazarou, E., Christaki, E., Domazou, M., Γαλανός, Α., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.868298 · Cited by 3
Youssef, L., Bourgin, M., Durand, S., Aprahamian, F., Lefevre, D., Maiuri, M. C., Marcangeli, V., Dulac, M., Hajj‐Boutros, G., Buckinx, F., et al. (2023) · Metabolites · doi:10.3390/metabo13020198 · Cited by 3
“Thus, when low muscle mass and function are combined with excess adiposity, being obese and old becomes a double health burden [3].”
BackgroundClinical impact of sarcopenia for overweight or obese patients with colorectal cancer
Chen, W., Lin, F., Yu, D., Ren, Q., Zhang, F., Shen, Z.-L., Chen, W., Dong, Q., & Yu, Z. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad139 · Cited by 3
Kozjek, N. R., Tonin, G., Puzigaća, L., Veninšek, G., Pirkmajer, S., Božič, T. K., Mastnak, D. M., Košir, J. A., Petrica, L., Berlec, K., et al. (2023) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3447 · Cited by 13
“Sarkopenija in maščobna masa ter njun medsebojni odnos pa neposredno določata prehransko in presnovno stanje posameznika (48).”
BackgroundHellénius, M.-L., Andermo, S., Nordenfelt, A., Lidin, M., Nyberg, L. A., & Nyberg, G. (2024) · Acta Paediatrica · doi:10.1111/apa.17274 · Cited by 3
Conte, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_7 · Cited by 5
Identification of Sarcopenic Obesity by Fat‐to‐Muscle Ratio in Older Adults: A Cohort Study
Kakita, D., Harada, K., Kurita, S., Morikawa, M., Nishijima, C., Fujii, K., Shimada, H., & Arai, H. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70174 · Cited by 2
Xuekelati, S., Abulitifu, Y., Maimaitiwusiman, Z., Xu, L., Guo, S., Xu, Q., Ke, J., & Wang, H. (2026) · Clinical Interventions in Aging · doi:10.2147/cia.s570497 · Cited by 2
“16 Concurrently, the ectopic lipid infiltration (myosteatosis) fueled by this inflammatory milieu introduces lipotoxicity, which impairs insulin signaling.”
Abbasi, M., Elyasinia, F., Jahromi, A., Farsi, F., Fard, R. J., Jahromi, N., Pirisedigh, A., Soroush, A., & Hasani‐Ranjbar, S. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08673-7 · Cited by 3
How to Diagnose Sarcopenic Obesity in Candidates for Bariatric Surgery?
Bacelar, G. B., Sampaio, E. F., de Santana, W. A., Lustoza, J. G., de Sousa, C. D., & Daltro, C. (2022) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2021.0085 · Cited by 2
“12,17,18 The scarcity of studies carried out in adults, young people, and obese people is another factor that contributes to a lack of consensus for this population.”
Risk of sarcopenia after bariatric surgery in patients with type 2 diabetes mellitus
Khitaryan, A. G., Abovyan, А. A., Ваграмович, М. А., Orekhov, A. A., Андреевич, М. Д., Sarkisyan, А. V., Адизов, С. А., Rogut, A. A., Ziegler, G. J., & Amegninou, M. J. C. (2022) · Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) · doi:10.21518/1995-1477-2022-19-2-142-151 · Cited by 2
IMPACTS OF AEROBIC EXERCISE ON THE OBESITY OF ADOLESCENTS AND THEIR LIPID METABOLISM
Ji, H., & Lirong, Y. (2022) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-8692202329012022_0163 · Cited by 5
Diagnosis and Management of Obesity: A Joint Statement by Practicing Endocrinologists
Barake, M., Echtay, A. S., Hirbli, K., Saab, C., Medlej, R., & Atallah, P. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.132008 · Cited by 2
Physiotherapeutic methods in complex treatment of obesity
Булина, О. В., Suslova, G. A., Kir’yanova, V. V., Suslov, V. M., Shakhova, N. A., Volkovskaya, A. N., Petrova, E. V., Egorova, Y. S., Либерман, Л. Н., Адулас, Е. И., et al. (2023) · Fizioterapevt (Physiotherapist) · doi:10.33920/med-14-2305-09 · Cited by 2
Advancements in Clinical Diagnosis and the Application of Auxiliary Imaging in Sarcopenic Obesity
Wang, H., Xiao, Y., Han, L., Lyu, G., Lin, S., & Li, S. (2025) · Obesity Facts · doi:10.1159/000547689 · Cited by 3
“Physical inactivity has also been identified as a risk factor for SO [24], with obesity and sarcopenia exerting synergistic effects on physical impairment and metabolic disorders (Fig.”
Geng, Y., Gu, S., Fan, Y., Lu, X., Zhou, Z., Zhang, N., Pei, Y., Lu, X., Borné, Y., & Ke, C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.09.018 · Cited by 5
Xu, Y., Wang, X., Chen, J., Kang, M. C., Wang, Y., Zhang, L.-J., Shu, H., Liao, X., Zou, J., Wei, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.914039 · Cited by 3
“All HCs met the following criterion: (1) 24 ≥ BMI ≥ 20; (2) can undergo an MRI scan; (3) head MRI shows normal brain parenchyma; (4) no mental illness; and (5) no diseases that may cause changes in fMRI (systemic diseases, degenerative diseases, demyelinating diseases, and autoimmune diseases).”
BackgroundMethodInfluentialTHE RELATIONSHIP BETWEEN BODY MASS INDEX AND LIFE SATISFACTION AMONG ADULT RUSSIANS
Gromova, D., & Алексеевна, Х. Н. (2023) · Social Aspects of Population Health · doi:10.21045/2071-5021-2023-69-1-5 · Cited by 5
Almeida-Menezes, A. F., da Conceição‐Machado, M. E. P., Gusmão, M. H. L., Ramos, L. B., do Nascimento, T. V. N., Amaral, M. T. R., & Medeiros, J. M. B. (2025) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2023.0232.r2.21102024 · Cited by 1
“Despite this, the accumulation of muscle fat and some metabolic abnormalities, such as increased oxidative stress, insulin resistance, and inflammation, have been identified as determinants, 38 and oxidative stress induced by cigarette substances aggravate DAO.”
Ma, M., Tang, Z.-L., Chen, L.-P., Qin, X.-N., Xiao, K.-F., Zhu, W., Zhang, Y., & Gong, Z. (2025) · Cells · doi:10.3390/cells14120874 · Cited by 1
“Individuals with obesity demonstrate considerable impairments in skeletal muscle quality and function, primarily due to the progressive deterioration of muscle architecture and lipid infiltration [1,2].”
Differing dietary patterns according to body composition
Lee, Y.-C., Kim, H.-M., Lee, H. S., Jeon, S., Kwon, Y., & Lee, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1509620 · Cited by 2
Godziuk, K., Vieira, F. T., Forhan, M. A., Batsis, J. A., Donini, L. M., González, M. C., Siervo, M., & Prado, C. M. M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.11.143 · Cited by 3
Interrelationships between Sarcopenia, Bone Mass, and Metabolic Parameters in Pediatric Obesity
Mikulska, M., Czepczor‐Bernat, K., Sawielew, K., Dolibog, P., Dolibog, P., & Matusik, P. (2026) · Annals of Nutrition and Metabolism · doi:10.1159/000549799 · Cited by 1
Sarcopenic obesity and metabolic disorders in ageing
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Косарева, О. В., Sharonova, L. A., Dolgikh, Y. A., & Merzlova, P. Y. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-134-147 · Cited by 2
Lin, C., Wu, H., Yu, N., Liu, Y.-C., & Chien, W. U. C. (2026) · Geriatric Nursing · doi:10.1016/j.gerinurse.2026.103961 · Cited by 1
Kim, J. R., Park, H. R., Song, P., & Joo, E. Y. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.109134 · Cited by 1
Buch, A., Magid, A., Eldor, R., Keinan‐Boker, L., Haim, L. B., Greenman, Y., & Stern, N. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111112 · Cited by 2
Sabico, S., & Al‐Daghri, N. M. (2021) · Practical issues in geriatrics · doi:10.1007/978-3-030-80038-3_11 · Cited by 1
Wakabayashi, H. (2021) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.58.627 · Cited by 1
Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery
Morgan, H., Ezad, S. M., Rahman, H., Silva, K. D., Partridge, J. S. L., & Perera, D. (2023) · Heart International · doi:10.17925/hi.2023.17.2.6 · Cited by 4
Safonicheva, O. G., Zaborova, V., Lazareva, I., Kryuchkova, K. Y., Bolotskaya, A. A., Ovchinnikova, M., Popova, C. Y., Putilo, V., Rybakov, V., Kotovskiy, S., et al. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s433944 · Cited by 1
“22 In addition, the contribution of inflammatory markers, including those secreted by adipocytes, to the development and progression of such classical CHD risk factors as obesity and hypertension is now reliably shown.”
BackgroundObésité sarcopénique : des étapes décisives et des perspectives prometteuses
Boirie, Y., Guillet, C., Pouget, M., Walrand, S., & Pinel, A. (2023) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(24)00009-8 · Cited by 1
Self-citationPalca, J. G., Reck, H. B., de Oliveira, G. H., Deprá, P. P., Porto, F. E., & Lopes, W. A. (2024) · Conexões · doi:10.20396/conex.v22i00.8674691 · Cited by 1
Troshina, E. A., Bogdanova, V. O., & Umarkhadzhieva, Z.-S. R. (2025) · Obesity and metabolism · doi:10.14341/omet13180 · Cited by 1
Sarcopenic obesity - current view
Pekár, M., Pekařová, A., Chovancová, T., & Holéczy, P. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.007 · Cited by 2
“K lepšímu pochopení by tedy pomohlo nastolení konsensu diagnostických kritérií, zdokonalení znalostí o patofyziologických pochodech v tukové tkáni a kosterních svalech na molekulární úrovni, rozšíření randomizovaných studií na všechny věkové skupiny, získání jednoduchého a levného způsobu diagnostiky sarkopenické obez…”
Sarcopenia e excesso de peso em mulheres portadoras de lúpus eritematoso sistêmico
Monteiro, J. R. S., Cardoso, M. C. C. M., de Oliveira, A. C. M., & Santos, J. C. D. F. (2021) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfex.v20i2.4410 · Cited by 2
Asús, N. (2022) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000263
Ma, X., Sun, G., Liu, C., Yan, X., Liang, W., & Ma, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1859967
Boschetti, D. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.89.2019.tde-10122019-121141
de Oliveira, F. L., Vieira, R. D. F. F. A., Melhem, A. R. D. F., Schiessel, D. L., Franco, S., & Cavagnari, M. A. V. (2021) · Braspen Journal · doi:10.37111/braspenj.2020354008
Cherian, P., Al‐Khairi, I., Jamal, M. H., Al‐Sabah, S., Ali, H., Dsouza, C. L., ALSHAWAF, E. M. M., Al-Ali, W., Al‐Khaledi, G., Al‐Mulla, F., et al. (2021) · Preprints.org · doi:10.20944/preprints202104.0655.v1
“Obesity and diabetes are the cause of several complications associated with the musculoskeletal system including osteoporosis and sarcopenia [3, 4].”
BackgroundBoirie, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-76753-1.00067-9
Self-citationOppert, J. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-76753-1.00001-1
“Incorporating a Gym Facility in a Lifestyle Medicine Practice for Patients with Diabetes Mellitus”
Nadolsky, K. Z., Baraki, A., & Nadolsky, S. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221089898 · Cited by 2
Definizione e diagnosi di obesità sarcopenica: la Consensus ESPEN e EASO
Parrinello, E., Busetto, L., Frara, S., Giustina, A., Laviano, A., Lenzi, A., Poggiogalle, E., Santini, F., Vettor, R., Zamboni, M. M., et al. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01138-w
Self-citationÖztorun, H. S., Bahşi, R., Turgut, T., Sürmeli, D. M., Coşarderelioğlu, Ç., Atmış, V., Yalçın, A., Aras, S., & Varlı, M. (2022) · European Journal of Geriatrics and Gerontology · doi:10.4274/ejgg.galenos.2022.2022-3-3 · Cited by 1
Obesity, inflammation and muscle weakness
Hasselgren, P.-O. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90960-0.00014-x · Cited by 1
Metadata
- Authors
- Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R.
- Affiliations
- University of Trieste (IT)
- University of Hohenheim (DE)
- University of Padua (IT)
- Uppsala University (SE)
- Tel Aviv University (IL)
- Medical University of Graz (AT)
- Istanbul University-Cerrahpaşa (TR)
- ORCID
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 11
- Issue
- 4
- Pages
- 294-305
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC6189532
- OpenAlex
- W2883874811
- Cited by
- 244
- References
- 92
- Citations by year
- 2026: 33 · 2025: 26 · 2024: 31 · 2023: 46 · 2022: 39 · 2021: 37 · 2020: 18 · 2019: 11 · 2018: 3
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc-nd)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, obesity, skeletal muscle mass, muscle function, frailty, body composition, diagnostic criteria, nutritional therapy, weight loss, chronic comorbidities
- MeSH terms
- Body Composition, Diet, Humans, Life Style, Obesity, Risk Factors, Prevalence, Muscle, Skeletal, Adiposity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.